Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syrio is an Italian healthcare company specializing in the development and distribution of high-quality food supplements, medical devices, and dermocosmetic products. Founded in 2007 and headquartered in the Brescia region, the company focuses on wellness and prevention through innovative formulations sold primarily through pharmaceutical and parapharmaceutical channels. Syrio operates as a subsidiary of Equilibra, which was acquired by Unilever in 2018 to bolster its presence in the health and wellness market. The company's portfolio includes well-known brands such as B-Lift, which offers advanced skincare solutions targeting anti-aging and skin repair. Syrio maintains a strong commitment to scientific research and quality standards to ensure the efficacy of its diverse product range.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syrio.